NAT-GEFITINIB
Identification of Nat-Gefitinib
| No description |
Google image searchProduct monograph
Active ingredient
gefitinib, 250 MG
DIN: 02491796
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 13-NOV-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EB01 — GEFITINIB (ATC/DDD)
Reference brand drug: Iressa
